scholarly journals Vaccination against Canine Distemper Virus Infection in Infant Ferrets with and without Maternal Antibody Protection, Using Recombinant Attenuated Poxvirus Vaccines

2000 ◽  
Vol 74 (14) ◽  
pp. 6358-6367 ◽  
Author(s):  
Janet Welter ◽  
Jill Taylor ◽  
James Tartaglia ◽  
Enzo Paoletti ◽  
Charles B. Stephensen
Keyword(s):  
Canine Distemper Virus ◽  
Clinical Signs ◽  
Neutralizing Antibody ◽  
Maternal Antibody ◽  
Canine Distemper ◽  
Parenteral Immunization ◽  
Multiple Routes ◽  
Antibody Titers ◽  
Group 3 ◽  
Rabies Glycoprotein

ABSTRACT Canine distemper virus (CDV) infection of ferrets is clinically and immunologically similar to measles, making this a useful model for the human disease. The model was used to determine if parenteral or mucosal immunization of infant ferrets at 3 and 6 weeks of age with attenuated vaccinia virus (NYVAC) or canarypox virus (ALVAC) vaccine strains expressing the CDV hemagglutinin (H) and fusion (F) protein genes (NYVAC-HF and ALVAC-HF) would induce serum neutralizing antibody and protect against challenge infection at 12 weeks of age. Ferrets without maternal antibody that were vaccinated parenterally with NYVAC-HF (n = 5) or ALVAC-HF (n = 4) developed significant neutralizing titers (log10 inverse mean titer ± standard deviation of 2.30 ± 0.12 and 2.20 ± 0.34, respectively) by the day of challenge, and all survived with no clinical or virologic evidence of infection. Ferrets without maternal antibody that were vaccinated intranasally (i.n.) developed lower neutralizing titers, with NYVAC-HF producing higher titers at challenge (1.11 ± 0.57 versus 0.40 ± 0.37, P = 0.02) and a better survival rate (6/7 versus 0/5, P = 0.008) than ALVAC-HF. Ferrets with maternal antibody that were vaccinated parenterally with NYVAC-HF (n = 7) and ALVAC-HF (n = 7) developed significantly higher antibody titers (1.64 ± 0.54 and 1.28 ± 0.40, respectively) than did ferrets immunized with an attenuated CDV vaccine (0.46 ± 0.59;n = 7) or the recombinant vectors expressing rabies glycoprotein (RG) (0.19 ± 0.32; n = 8,P = 7 × 10−6). The NYVAC vaccine also protected against weight loss, and both the NYVAC and attenuated CDV vaccines protected against the development of some clinical signs of infection, although survival in each of the three vaccine groups was low (one of seven) and not significantly different from the RG controls (none of eight). Combined i.n.-parenteral immunization of ferrets with maternal antibody using NYVAC-HF (n = 9) produced higher titers (1.63 ± 0.25) than did i.n. immunization with NYVAC-HF (0.88 ± 0.36; n = 9) and ALVAC-HF (0.61 ± 0.43; n = 9, P = 3 × 10−7), and survival was also significantly better in the i.n.-parenteral group (3 of 9) than in the other HF-vaccinated animals (none of 18) or in controls immunized with RG (none of 5) (P = 0.0374). Multiple routes were not tested with the ALVAC vaccine. The results suggest that infant ferrets are less responsive to i.n. vaccination than are older ferrets and raises questions about the appropriateness of this route of immunization in infant ferrets or infants of other species.

scholarly journals Canine Distemper Epizootic in Lions, Tigers, and Leopards in North America

1994 ◽  
Vol 6 (3) ◽  
pp. 277-288 ◽  
Author(s):  
Max J. G. Appel ◽  
Rebecca A. Yates ◽  
George L. Foley ◽  
Jon J. Bernstein ◽  
Silvio Santinelli ◽  
...  
Keyword(s):  
Canine Distemper Virus ◽  
Clinical Signs ◽  
Neutralizing Antibody ◽  
Panthera Tigris ◽  
Canine Distemper ◽  
Antibody Testing ◽  
Source Of Infection ◽  
San Fernando ◽  
Antibody Titers ◽  
Different Strains

Canine distemper virus (CDV) infection occurred in captive leopards ( Panthera pardus), tigers ( Panthera tigris), lions ( Panthera leo), and a jaguar ( Panthera onca) in 1991 and 1992. An epizootic affected all 4 types of cats at the Wildlife Waystation, San Fernando, California, with 17 mortalities. CDV-infected raccoons were thought to be the source of infection in these cats. Two black leopards died at the Naibi Zoo, Coal Valley, Illinois, and 2 tigers died at the Shambala Preserve, Acton, California. Initial clinical signs were anorexia with gastrointestinal and/or respiratory disease followed by seizures. Canine distemper virus was isolated from 3 leopards, 3 tigers, and 3 lions that died or were euthanized when moribund. Monoclonal antibody testing identified the virus isolates as CDV. Gross and histopathologic findings were similar to those found in canids with distemper with a few exceptions. There were fewer lesions in the brain, and there was a pronounced type 2 cell proliferation in the lung, with inclusion bodies and CDV antigen demonstrated by immunohistology. Neutralizing antibody to CDV was found in high titers in serum from most animals but was absent or was found only in low titers in some cats that succumbed after CDV infection. There was a marked difference in neutralizing antibody titers when tests were done with different strains of CDV.

scholarly journals Natural Canine Distemper Virus Infection in Linnaeus’s 2-Toed Sloths (Choloepus didactylus)

2020 ◽  
Vol 57 (2) ◽  
pp. 311-315 ◽  
Author(s):  
Allison M. Watson ◽  
Andrew C. Cushing ◽  
Julie D. Sheldon ◽  
Eman Anis ◽  
Rebecca P. Wilkes ◽  
...  
Keyword(s):  
Virus Infection ◽  
Canine Distemper Virus ◽  
Clinical Signs ◽  
Hepatic Necrosis ◽  
Nasal Discharge ◽  
The Novel ◽  
Canine Distemper ◽  
The Central Nervous System ◽  
Lymphoid Depletion ◽  
Viral Sequencing

An outbreak of canine distemper virus in a private zoo in eastern Tennessee in July 2016 led to fatal clinical disease in 5 adult, wild-caught Linnaeus’s 2-toed sloths ( Choloepus didactylus). Clinical signs included hyporexia, lethargy, mucopurulent nasal discharge, and oral and facial ulcers. At necropsy, affected animals had crusts and ulcers on the lips, nose, tongue, and oral cavity. Microscopically, all sloths had widespread, random, hepatic necrosis; lymphoid depletion; and bronchointerstitial pneumonia. The central nervous system did not contain gross or histopathologic lesions in any of the 5 sloths, although immunoreactivity for viral antigen was present within vessel walls. Epithelial cells and histiocytes within numerous organs contained intranuclear and intracytoplasmic inclusions and occasional syncytial cells. Canine distemper virus was confirmed with immunohistochemistry and virus isolation. Viral sequencing identified the novel American-4 strain prevalent in eastern Tennessee wildlife. This is the first pathologic characterization of canine distemper virus infection in sloths (family Choloepodidae, order Pilosa) and emphasizes the significant morbidity and mortality in this species.

scholarly journals Canine Distemper Virus Antigen Detection in External Epithelia of Recently Vaccinated, Sick Dogs by Fluorescence Microscopy Is a Valuable Prognostic Indicator: TABLE 1

2014 ◽  
Vol 53 (2) ◽  
pp. 687-691 ◽  
Author(s):  
Sanjay Kapil ◽  
Tina Neel
Keyword(s):  
Clinical Outcomes ◽  
Respiratory Disease ◽  
Canine Distemper Virus ◽  
Fluorescent Antibody ◽  
Clinical Signs ◽  
Antibody Test ◽  
Prognostic Indicator ◽  
Symptomatic Therapy ◽  
Canine Distemper ◽  
Clinical Recovery

Currently, there are no reliable predictors of the clinical outcomes of domesticated dogs that have been recently vaccinated against canine distemper virus (CDV) and develop respiratory disease. In this study, vaccinated dogs from Oklahoma City that were showing clinical signs of respiratory disease were evaluated for CDV antigen using a direct fluorescent antibody test (FAT). Clinical outcomes after standard symptomatic therapy for respiratory disease were recorded, and a statistical analysis of the results was performed. We present our study showing that CDV FAT results were predictive of clinical recovery (prognostic indicator, prospects of clinical recovery) among vaccinated dogs showing clinical signs of respiratory disease. Negative CDV FAT results equated to 80% chances of recovery after symptomatic therapy, compared to 55% chances of recovery when the CDV FAT results were positive. Based on the results of this study, we show that veterinarians can make better informed decisions about the clinical outcomes of suspected CDV cases, with 2-h turnaround times, by using the CDV FAT. Thus, antemortem examination with the CDV FAT on external epithelia of recently vaccinated, sick dogs is a clinically useful diagnostic test and valuable prognostic indicator for veterinarians. Application of the CDV FAT to these samples avoids unnecessary euthanasia of dogs with suspected CDV.

Seroconversion of puppies to canine parvovirus and canine distemper virus: a comparison of two combination vaccines

2000 ◽  
Vol 36 (2) ◽  
pp. 137-142 ◽  
Author(s):  
MJ Coyne
Keyword(s):  
Canine Distemper Virus ◽  
Serum Antibody ◽  
Canine Parvovirus ◽  
The Other ◽  
Canine Distemper ◽  
Combination Vaccines ◽  
Antibody Titers ◽  
The Mean ◽  
To Receive ◽  
Mean Time

Sixty puppies were randomly assigned to receive one of two commercially available combination vaccines, and responses to the canine parvovirus and canine distemper virus components of the vaccines were determined by measuring serum antibody titers. The percentage of puppies that seroconverted to canine parvovirus was significantly higher and the mean time for seroconversion was significantly shorter for puppies that received one of the vaccines than for puppies that received the other vaccine. Percentages of puppies that seroconverted to canine distemper virus were not significantly different.

CANINE DISTEMPER VIRUS ANTIBODY TITERS IN DOMESTIC CATS AFTER DELIVERY OF A LIVE ATTENUATED VIRUS VACCINE

2016 ◽  
Vol 47 (2) ◽  
pp. 551-557 ◽  
Author(s):  
Edward Ramsay ◽  
Ryan Sadler ◽  
Robert Rush ◽  
Tracie Seimon ◽  
Ania Tomaszewicz ◽  
...  
Keyword(s):  
Virus Vaccine ◽  
Canine Distemper Virus ◽  
Domestic Cats ◽  
Canine Distemper ◽  
Virus Antibody ◽  
Attenuated Virus ◽  
Antibody Titers

scholarly journals Nanoparticles of Conformation-stabilized Canine Distemper Virus Hemagglutinin are Highly Immunogenic and Induce Robust Immunity

2020 ◽  
Author(s):  
Hao Feng ◽  
Jingjian Dong ◽  
Yan Chen ◽  
Lili Shi ◽  
Bing Shen ◽  
...  
Keyword(s):  
Immune Responses ◽  
Self Assembly ◽  
Canine Distemper Virus ◽  
Systemic Disease ◽  
Neutralizing Antibody ◽  
Canine Distemper ◽  
Igg Antibody ◽  
Organ Systems ◽  
New Type ◽  
H Protein

Abstract BackgroundCanine distemper virus (CDV) infection of ferrets, dogs, and giant pandas causes an acute systemic disease involving multiple organ systems, including the respiratory tract, lymphoid system, and central nervous system. In this study, we tested a new type candidate CDV vaccine–CDV nanoparticles–based on hemagglutinin protein. MethodsThe nanoparticles were generated from conformation-stabilized CDV hemagglutinin tetramers. Immune responses against CDV were evaluated in mice. Immunization was initiated 6 weeks after birth and boosted twice with 4-week intervals. The blood and mucosal samples were collected 2 weeks after each immunization. ResultsVaccination with CDV nanoparticles elicited high levels of IgG antibody titers in mice (approximately seven- to eight fold higher than that obtained with soluble CDV H protein), as well as mucosal immune responses, and developed increased CDV-specific neutralizing antibody. The mice that received nanoparticles showed significantly higher IFN-γ- and IL-4-secreting cell population in the spleen and lymph node compared with mice immunized with soluble H protein. The co-stimulatory molecular expression of CD80 and CD86 on the surface of DCs were also upregulated. ConclusionThe results demonstrate that self-assembly into nanoparticles can increase the immunogenicity of vaccine antigens, and nanoparticles assembled from conformation-stabilized CDV H protein has the potential to serve as a new type CDV vaccine.

Sign in / Sign up

Export Citation Format

Share Document